Skip to main content

Measles Update: Clinical Management and Facility Preparedness- February 20, 2026

Page 1


MEASLES UPDATE: CLINICAL

MANAGEMENT AND FACILITY PREPAREDNESS

Regina Chinsio-Kwong, DO

Anissa Davis, MD, MPH

Christopher Zimmerman, MD, MPH Orange County Health Care Agency

February 20, 2026

AGENDA

Clinical presentation and Infection Control

Epidemiology and Surveillance

DISCLOSURE STATEMENT

The speakers for this Continuing Medical Education (CME) activity have no relevant financial relationships or disclosures with any commercial interests related to the content of this presentation.

MEASLES VIRUS

• RNA Virus

• Only infects humans

• It is a paramyxovirus and so distantly related to Mumps and parainfluenza virus

• Measles Virus (MeV) is most closely related to rinderpest virus (RPV) which has been eradicated

• A recent study suggested that MeV and RPV diverged about that time that humans first started living in large cities roughly 3,000 years ago

MEASLES IN THE PRE-VACCINE ERA

• In the US measles became nationally notifiable disease in 1912

• In the first 10 years of reporting 6,000 deaths were reported per year

• In the decade before vaccine became available 1953-1963

• Nearly all children were infected by 15 years of age

• Each year:

• 3-4 million cases

• 400-500 measles deaths

• 48,000 measles hospitalizations

• 1,000 cases of encephalitis

CLASSIC MEASLES

• Prodromal illness of

• Malise

• Cough

• Coryza

• Conjunctivitis

• Sometimes Koplik spots

• Fever

• Rash

• Maculopapular rash

• Starting on the face spreading down the body and out to extremities

Koplik Spots

MEASLES DISEASE

• Incubation period

• Typically, 14 days after exposure but can range from 7-21 days

• Infectious Period

• Measles is the most contagious disease known

• Airborne transmission

• People with measles are infectious from 4 days before through 4 days after rash onset

FEVER AND RASH ILLNESS

• Fever and rash is a common presentation of many viral illness in children and adults

• Enteroviruses Measles

• Varicella Measles Vaccine

• HIV Human Herpes Virus 6 and 7

• Parvovirus B 19 Rubella

• Fever and rash can also be can also have bacterial causes

• Scalet fever Impetigo

• Pseudomonas folliculitis Neisseria (meningococcemia, gonococcemia)

• Non- infectious

• Allergic reactions/ drug reactions Erythema multiforme

NOT EVERYTHING IS CLASSIC

• Public Health is looking for clinical suspicion of measles

• Measles is not a clinical diagnosis

• We want lab confirmation or rule out

• Degree of contagiousness

• Consequences of missing cases

• Viral testing allows us to do molecular epidemiology link cases to others to identify gaps in surveillance

714-834-8180 (24/7)

• CONSIDERING MEASLES

• What is the local epidemiology

• Make sure you are signed up for CD Health Alerts

• Known exposure to measles

• Travel International? Domestic?

• Visiting large venues (concerts, amusement parks)

• Measles Immunity status

MEASLES IN ADULTS

• It happens!

• 23% of measles cases reported to CDC since January 2025 have been in those 20+ years of age

• The same considerations should be made as when evaluating children

• Local epidemiology, exposures, travel, immunization status

• Providers include measles in the differential diagnosis when evaluating patients https://pmc.ncbi.nlm.nih.gov/articles/PMC6910791/

WHY CALL CDCD

• Legal responsibility

• Suspected measles is immediately reportable per Title 17 Section 2500

• We can

• Help expedite testing

• Discuss specimen collection requirements

• Approve testing at the OC Public Health Laboratory

• Arrange specimen transport

• Provide Infection control recommendations

• Isolation measures

• Exposed Contacts

• Provide Postexposure prophylaxis recommendations

• MMR

• Immunoglobulin

TESTING FOR MEASLES

• Viral Testing (PCR for Measles Virus)

• OC Public Health Lab (PHL) can turn around a result quickly usually within 24 hours of receipt

• Use synthetic swab (no cotton or wood)

• Place in viral transport media (VTM) or Universal transport media (UTM)

• Sources (two sources preferred)

• Oral pharyngeal (easiest and most preferred by the lab)

• Nasopharyngeal

• Urine (not required except in cases that rash was >4 days ago)

• You MUST call CDCD for a specimen to be accepted

SEROLOGICAL TESTING

• Measles IgM testing used to be the go-to test, but no longer

• Sensitivity and specificity of PCR is much better

• Can be helpful for late diagnosis

• IgG testing can confirm immunity in someone without vaccination records

• Commercial labs or OC PHL can do serological testing both IgG and IgM testing through CDCD

EARLY COMPLICATIONS OF MEASLES

• Early compilations

• Dehydration

• Viral pneumonia

• Secondary bacterial pneumonias

• Encephalitis 1/1,000

• Death from respiratory or CNS complications

1-3/1,000

LATE COMPLICATIONS OF MEASLES

• Hearing loss

• Encephalitis

• Immune amnesia

• Loss of existing repertoire of memory B-cells and T-cells

• May last for 2-3 years

• Subacute sclerosing panencephalitis (SSPE)

• Occurrence 7-11/100,000

• Uniformly fatal progressive neurodegenerative process

• Risk is highest for those infected in infancy

IMMUNITY TO MEASLES

• Documentation of 2 doses of MMR vaccine

• Birth prior to 1957

• Documentation of a positive measles IgG titer

WHO IS HIGH-RISK FOR MEASLES COMPLICATIONS

• Infants < 1 year of age

• Immunocompromised without prior immunity

• Pregnant people

• Severely immunocompromised

• Primary immunodeficiencies

• Chemo

• HIV with CD4 counts < 200

• Immunosuppressive therapy

MEASLES POST-EXPOSURE PROPHYLAXIS (PEP)

• Persons with documented immunity do not need PEP

• MMR

• Anyone without prior immunity without a contraindication should receive MMR vaccine within 72 hours of exposure

• Includes children 6-11 months of age

• Immunoglobulin (IG) PEP

IMMUNOGLOBULIN (IG) FOR MEASLES PEP

• For those with contraindication to MMR vaccine

• Infants < 6 months, severely immunocompromised, non-immune pregnant people

• May be administered up through 6 days after initial exposure

• After 6 days IG PEP is not indicated as it is too late to interrupt illness

• Those who receive IG PEP must quarantine for 28 days from last exposure

MEASLES TREATMENT

• There is no specific treatment for Measles

• Vitamin A is recommended for children and adults diagnosed with measles

"Vitamin A does not prevent measles and is not a substitute for vaccination.

Consistent with guidance from the American Academy of Pediatrics, vitamin A may be administered to infants and children in the United States with measles under the supervision of a healthcare provider as part of supportive management.

Children with severe measles, such as those who are hospitalized, should be managed with vitamin A.

Overuse of Vitamin A can lead to toxicity and cause damage to the liver, bones, central nervous system, and skin. Pregnant women should avoid taking high levels of vitamin A as it has been linked to severe birth defects."

From CDC Clinical Overview of Measles

HTTPS://WWW.CDC.GOV/MEASLES/HCP/CLINICALOVERVIEW/INDEX.HTML ACCESSED FEBRUARY 20, 2026 OC HEALTH CARE AGENCY | 21

EPI& SURVEILLANCE

MEASLES GLOBALLY, 6/25 THRU 11/25

MEASLES GLOBALLY 2025

248,000 MEASLES CASES

179 WHO MEMBER COUNTRIES

• 6 European Countries Recently Lost

Elimination Status:

• Armenia

• Austria

• Azerbaijan

• Spain

• United Kingdom

• Uzbekistan

• Other Countries with Endemic Measles

• France • Germany • Canada

India

Cambodia

Philippines

Vietnam

Italy • China?

MEASLES REGIONALLY THE AMERICAS, 2025-2026

2025/26

• 17,226 cases

• 31 deaths

• 12 countries and the Caribbean

MEASLES IN MEXICO

PARTICULARLY CONCERNING RIGHT NOW

CDC MEASLES DATA FROM 2025-2026

While majority of those hospitalized occurred in those < 5, they also occurred in adults

FROM HTTPS://WWW.CDC.GOV/MEASLES/DATARESEARCH/INDEX.HTML (LAST UPDATED FEBRUARY 20 , 2026) OC HEALTH CARE AGENCY | 27

Outbreaks in Several States

• South Carolina

• Arizona

• Utah

• Florida

Many states have very few cases

MEASLES CASES AND OUTBREAKS | MEASLES

2025-2026 Measles OutbreaksCultural or Religious Community Characteristics

Southwest Utah 2025-2026

Multiple churches/congregations

Hildale, Utah and Colorado City

Arizona 2025-2026

Fundamentalist LDS (FLDS)

Vaccine rates among Kindergarten children: 7-17%

El Paso, Texas

Adult population- (2/3 cases)

School age (7%)

clustered in schools/clinics

Gaines County, Texas 2025

Old Colony Mennonite, Plautdietsch (low German speaking) community

Spartanburg County, SC 2026

Eastern European/Slavic Immigrant Communities- Eastern European immigrant and Slavicspeaking households

OC

Florida College

COMMUNITIES WITH PREVIOUS HISTORY OF LOW VACCINE RATES

• Factors contributing to lower vaccination rates with certain groups

• religious beliefs that prioritize spiritual approaches to health

• concerns about vaccine safety

• historical experiences

• mistrust of government

• strong emphasis on personal and religious freedoms

Posted Press Releases across California

Napa

County

January 21, 2026

• Child returning from South Carolina

Orange County

January 28, 30, 31, 2026

• Young Adult - recently returned from international travel

• Toddler (no travel)

• LA case - traveled to Disneyland on January 28 (infectious period)

February 7, 2026

• Visitors from another county who visited Disney January 22

Riverside

Los Angeles

February 9, 2026

• Unvaccinated child without history of international or out of state travel

February 13, 2026

• Outbreak- 1 adult and 1 child

January 30 and 31, 2026

• Resident who recently travelled internationally

• International traveler February 2, 2026

• Resident who traveled internationally February 19, 2026

• Resident returning from international travel

Shasta County

January 31, 2026

• Minor- who returned from travel to San Francisco and Southern California February 10, 19, 2026- Outbreak- 8 cases

San Bernardino

February 6, 2026

• Unvaccinated minor visiting from another state

San Mateo

January

• Unvaccinated Adult returned from international travel

MEASLES- ORANGE COUNTY CASES AND EXPOSURES

• 1/28 Adult who recently traveled internationally

• Sites case visited during infectious period:

• gym

• Urgent care

• Hospital

• 159 total contacts

• 1/30 Toddler without travel

• History of visitation to local public venue with many other international visitors during incubation period

• Patient isolated and fully vaccinated provider took sample at car

• No known exposures during infectious period

• 1/31 Los Angeles County Case

• International traveler who visited Disneyland while infectious 1/28/26

• 65 known exposures (restaurant staff)

• 2/6 Confirmed Case Visitor to OC

• Sites visited while infectious:

• Disneyland

• Dance studio

• Medical clinic

• 84 total contacts

SUSPECTED MEASLES CASE

DO NOW – BEFORE A CASE

Protocol to:

• Identify suspect measles cases ASAP

• Place them in an airborne infection isolation room (AIIR), if available or a private room with door closed ASAP

• Evaluate suspects outside if no AIIR

• Call Public Health immediately for any suspect case (714) 834-8180

• Call ahead if you refer patient out

• Train triage staff to rapidly recognize measles symptoms

• Determine which rooms most suitable (distance & high-risk people)

• Ensure all staff have documentation of immunity to measles

• Ensure you have PPE and providers are fit tested

• Identify measles strike team

• Logistics of testing and PEP administration

HTTPS://WWW.CDPH.CA.GOV/PROGRAMS/CID/DCDC/ CDPH%20DOCUMENT%20LIBRARY/IMMUNIZATION/M EASLES - HCFACILITYICRECS.PDF

MEDICAL

EVALUATION OF SUSPECTED MEASLES CASE

• Isolate and mask patient

• Ask about symptoms & epi risk factors:

• Epi risk factors in past 21 days

• Vaccination status of patient

• Symptoms: fever, rash (when and where), 3 C’s

• All healthcare workers entering the patient room regardless of immune status should use respiratory protection (N95)

• Limit staff & visitors entering isolation room

• Staff not known to be immune should not enter room

• Contact your infection control staff

• Keep exam room vacant for one hour before cleaning

• Standard cleaning procedures

• Patient instructions:

• stay home until measles is ruled out or until 4 days after rash onset

• public health will be calling

• Call ahead or inform healthcare providers if they need to seek additional medical care

Epi Risk Factors

In the past 21 days:

• Known contact with measles case or an ill person with fever and rash

• Contact with an international visitor who arrived in US in the past 21 days

• Travel outside the US

• Domestic travel through an airport

• Visited a US venue popular with international visitors, such as theme parks, tourist attractions

• Lives in or visited a US community where there are measles cases

INFECTION CONTROL CONSIDERATIONS

•AIIR vs. room w door closed

•Closed room mitigates but may not eliminate risk of exposures due to shared air space

•Exposed persons are those who shared air space with patient, even if patient was masked

•Healthcare staff who wore appropriate PPE are still considered exposed

•There’s no guidance on length of time in shared airspace considered an exposure

•We will want proof of immunity in health workers

WHAT HAPPENS IF THERE'S A CASE

• 72 hour to 6-day window to provide prophylaxis (MMR or IG)

• Need to document when and where patient was in facility

• Line list of exposed staff and their immunity documentation

Those with no documented immunity by day 5 after exposure they will be excluded from work for up to 21 days

• Employer's responsibility

• Line list of exposed patients and visitors

• Particularly concerned for infants, pregnant people, severely immunocompromised

• We may need assistance reaching patients

• Plan for logistics of serologic testing, IVIG and IMIG and MMR

WHAT TO DO

GET STARTED WHILE WE WAIT FOR LAB RESULTS

• Identify

• Exposed Visitors/Clients/Patients and High- Risk Individuals

• Anyone in a shared airspace of the suspected case from an hour before until an hour after the person was put in isolation, consider waiting rooms, restrooms, hallways, offices where the person may have visited

• Are there expose who are high risk for severe disease (<12 months of age, severely immunocompromised, Non-immune pregnant women)

• Exposed staff

• Including healthcare, administrative, security, facilities, environmental staff, or any EMS workers present

• If you have Employee Health (EH), OC Public Health would expect EH to assess immunity of exposed staff

• Create a line list (be ready to share with Public Health)

• Include

• Name

• DOB

• Contact information, language

• measles immunity status if known

WHAT WILL PUBLIC HEALTH DO OR ASK FOR WHEN YOU CALL

THEM

• What is the story

• Public Health will ask: How old, when did rash start, where on the body did the rash start, did they have a known exposure, travel

• Specimen coordination

• Public Health can discuss how to collect specimens, we can arrange specimen transport, testing and results

• PLEASE DO NOT SEND PATIENTS TO PUBLIC HEALTH FOR TESTING

• Please call us (714) 834-8180 while patient is at your office

• Contacts

• Ask for line list of exposed

• Provide recommendations on exposed individuals

• Who needs Post-exposure prophylaxis (PEP), what type of PEP

• Who needs to quarantine

• Monitoring

• Non-immune exposed individuals will be monitored, by phone, for the length of quarantine

WHAT PROVIDERS & FACILITIES CAN DO

• Document staff immune status NOW

• This will help avoid work exclusions

• Give people time to find their documentation or to get titers drawn

• Prepare for potential increased staffing needs to respond

• A single case linked to your facility can require significant effort and coordination with local officials for rapid notification and to ensure safety and health of staff and visitors.

• Adjust clinical workflows and patient triage to minimize potential measles exposures

• Consider prescreening protocols

• For patients with cough, conjunctivitis, fever or rash, recent visit to areas with outbreaks

• Measles vaccination status

• Consider:

• Waiting outside

• Isolation protocols

• PPE protection REVIEW CDPH QUICKSHEET AT HTTPS://WWW.CDPH.CA.GOV/PROGRAMS/CID/DCDC/CDPH%20DOCUMENT%20LIBR

HOW DO I PROTECT MYSELF?

MMR vaccines are our best defense against the disease and its complications.

Vaccine Recommendations

Two doses of MMR (measles, mumps, rubella) vaccine for optimal protection

• Children: one dose at 12 months of age and another at 4–6 years

• Older children, adolescents and non-pregnant adults without documented doses of MMR vaccine:

• Two doses of MMR separated by at least 28 days

• Talk to your health care provider or visit MyTurn.ca.gov​ to make a vaccine appointment.​

• Unsure if you’re vaccinated against measles?

• Check your CA Digital Vaccine Record (DVR) or ask your healthcare provider.

• If no records exist, get vaccinated.​

SPECIAL INSTRUCTIONS

INTERNATIONAL TRAVEL OR TRAVEL TO AREAS WITH ONGOING OUTBREAKS

Whether you’re visiting family or exploring the world (or settings with potential of interaction with many travelers), ensure you are up to date with the MMR vaccine.

• Aim for getting vaccinated two weeks before departure or arrival of visitors. Before international travel or travel to regions with ongoing outbreaks consider following immunization for international travel:

• Babies 6–11 months of age should receive one dose of MMR vaccine *this is an additional dose and is not considered part of the 2-dose MMR vaccination for routine vaccines.

• Ensure everyone 12 months and older are up to date with two doses of MMR vaccine.

• If they’re not up to date, they should get two doses at least 28 days apart.

CLINICIANS- STAY UP TO DATE

Utilize resources from our website and Subscribe to our advisory list and monthly newsletter!

Orange County Health Care Agency Website

• www.ochealthinfo.com/

• https://www.ochealthinfo.com/services-programs/disease-prevention/diseasesconditions/measles

Health Corner Webpage

• www.ochealthinfo.com/healthcorner

Dashboards

• Communicable Disease Surveillance

https://ochealthinfo.com/cdcd/data

• Respiratory Virus Surveillance

https://www.ochealthinfo.com/respiratoryvirus

Provider Advisory List

Clinicians, receive immediate notification of communicable disease related alerts.

Sign up at this link: Provider Advisory Email Advisory.

Monthly Health Officer Clinician Newsletter

Subscribe to receive the County Health Officer newsletter by scanning the QR Code (right) or by entering your email here: Health Officer Newsletter Subscription

www.ochealthinfo.com/healthcorner

SUSPECT MEASLES?

For Communicable Disease Control contact #'s in other counties or cities across California, go to LHD Communicable Disease Contact List.

THANK YOU!

Q&A

Turn static files into dynamic content formats.

Create a flipbook
Measles Update: Clinical Management and Facility Preparedness- February 20, 2026 by County of Orange Health Care Agency - Issuu